$ARNA News S&P 500 back for another crack at major

New Post Public Reply Private Reply Replies (0) Message Board

Nov 3, 2014 at 11:44 AM

$ARNA News

S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy

Arena Pharmaceuticals (ARNA) Q3 2014 Results - Earnings Call Webcast 8:25 a.m. Today - Seeking Alpha
Super Important Biotech and Drug Stock Events for November 8:24 a.m. Today - TheStreet.com
Arena Pharmaceuticals Reports Q3 Loss, Shares Surge 6% 7:37 a.m. Today - benzinga.com
Arena Pharma Reports Q3 EPS Loss $0.05, Revenues Of $8.16M Vs. Est. Of $11.0M 5:48 a.m. Today - benzinga.com
Arena Pharmaceuticals, Inc., Loews Corporation, and Sysco Corporation: Today’s Earnings Movers 4:57 a.m. Today - InvestorPlace.com
Earnings Scheduled For November 3, 2014 4:18 a.m. Today - benzinga.com
Belviq Sales Recover From Holiday - Sales Flat In Q4 Thus Far 4:51 p.m. Oct. 31, 2014 - Seeking Alpha
Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected? - Analyst Blog 3:34 p.m. Oct. 31, 2014 - Zacks.com
Eisai Earnings Give Arena Investors Insights 10:33 a.m. Oct. 31, 2014 - Seeking Alpha
Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx 6:40 a.m. Oct. 31, 2014 - TheStreet.com
3 Pharma Companies Fighting Obesity 1:00 p.m. Oct. 30, 2014 - benzinga.com
Arena Offers Tease On Belviq And Phentermine 11:02 a.m. Oct. 29, 2014 - Seeking Alpha
Arena Skimps on Data Disclosure from Weight-Loss Combo Study 7:30 a.m. Oct. 29, 2014 - TheStreet.com
Belviq Sales Dip During Holiday Week, Should Show Steady Progress From Here 7:38 a.m. Oct. 27, 2014 - Seeking Alpha
Assessing Arena Pharmaceutical Belviq Sales And The Impact Of TV Ads 9:16 a.m. Oct. 22, 2014 - Seeking Alpha
Arena Investors Need To Watch Contrave Launch Closely 9:08 a.m. Oct. 22, 2014 - Seeking Alpha
Orexigen (OREX) Stock Shoots Higher as Contrave Goes on Sale 11:08 a.m. Oct. 21, 2014 - InvestorPlace.com
Orexigen Launches Contrave - Watch For Traction 2:01 p.m. Oct. 20, 2014 - Seeking Alpha
Belviq Sales Dip: What To Watch For Ahead 1:13 p.m. Oct. 17, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com

Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Today - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Today - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 5:20 p.m. Oct. 28, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3 7:00 a.m. Oct. 27, 2014 - PR Newswire - PRF
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 8:30 a.m. Oct. 17, 2014 - PR Newswire - PRF
Global Anti-Obesity Drugs Market 4:07 p.m. Oct. 16, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine 10:36 a.m. Oct. 10, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 7:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7:15 a.m. Sept. 19, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Post-Earnings Review and Highlights - Arena Pharma 8:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3:30 a.m. Aug. 1, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7:00 a.m. July 30, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category 7:00 a.m. July 29, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 7:00 a.m. July 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel 7:00 a.m. July 21, 2014 - PR Newswire - PRF
Cannabis Based Healing Products Lead Commercialization For Medical Marijuana Patients - Company Introduces New Edible CBD-Rich Product Line 7:30 a.m. July 16, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Brightstar Extends ONCE Contract for Spain Lottery Tech

Brightstar's Steady Hand in the Lottery Fray Now here's a story that's got a touch of nostalgia coupled with forward-thinking ambition. Brightstar Lottery PLC, the big kahuna if you're talking about lottery tech, just snagged a multi-year contract extension with Spain's ONCE— the folks known for funding social programs with their lotteries. It’s not just any little...

Equity Alerts: Unraveling the Latest M&A Surprises

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Bambu Lab Shakes Up 3D Printing with Massive Discounts

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...

Millrose Faces Class Action: Blame Game in Motion

Millrose Properties: A Realty Ruckus Unfolding Sometimes, in the world of stocks, it feels like you're two steps ahead of the scam or already knee-deep in trouble. Millrose Properties, Inc. struck a rather sour chord recently with an 8.53% stock drop, leaving investors feeling the burn. Here's the juice: a securities fraud class action is in motion, and if you're holding...

Paige Kaplan Randolph Spotlights on Hollywood Power List

From Law Books to Power Lists Cue the applause, folks! Paige Kaplan Randolph has just snagged a shiny badge of honor being named to The Hollywood Reporter's Power Reps: Creators List for 2026. This ain't some random nod; it's a recognition spotlighting legal stalwarts shaping the ever-morphing mosaic of entertainment. If you're wondering where the real power behind the...

Quantum Connections Elevates Griffeth to COO Role

James Griffeth Steps Up: A Strategic Shift Quantum Connections has handed James "Jamie" Griffeth the keys to the operational kingdom, elevating him to Chief Operating Officer. This isn't just any old promotion mind you—he'll also keep steering the ship as Director of the Dialogue Training Institute. It’s strategic moves like these that can make or break futures. The...

Vermilion Energy Sets Dates for Earnings and Calls

The Anticipation Around Vermilion's Upcoming Results There's a buzz in the air about Vermilion Energy Inc.'s upcoming Q3 2026 financial results. Slated to hit the wires November 4th, before the sun rises on Wall Street, folks in the trade have their eyes peeled to parse through any morsels of data. The question on everyone's mind? Whether they're making the right moves to...

Ransomware Hits The Money Store, Data at Risk

Ransomware in the Mortgage Sector Feels like data breaches are the new rainy day—unwelcome and unavoidable. This time, the storm hit MLD Mortgage Inc., otherwise known as The Money Store. You’d think that with a name like that, they'd keep a tight grip on their data. But nope, they've got a mess on their hands, and Edelson Lechtzin LLP is on the case, poking into this...

Asuri.ai Unveils Multi-Agent AI Platform for Business

Asuri.ai's Bold New Move into AI Workflows Picture the business world, bustling with nontechnical folks drowning in redundant tasks. Now toss a lifeline: Asuri.ai's fresh-off-the-presses multi-agent enterprise AI platform. This isn't just another tricked-out AI assistant; it's a serious game-changer on October 21, 2026. From Irvine, California, Asuri has kicked open a...

Factors Driving Up Car Window Tinting Costs Explained

Decoding the Dollars Behind Car Window Tinting When you think about car upgrades, window tinting might not scream excitement. But, my friends, it ain't all about the aesthetics. Dive into the nuts and bolts of cost with insights from Francis Alegre, a seasoned pro from StayShine Detailing in Voorhees, New Jersey, featured in HelloNation's rundown. The Glass Mass Factor...